top of page
  • Writer's pictureFutureMeds

Dealspan Makes Strategic Investment in FutureMeds

Updated: Jan 24, 2023

FutureMeds has completed a refinancing underpinned with investment from dealspan, a UK-based independent boutique investment firm.

Currently operating 6 sites in Poland, FutureMeds is growing towards being Europe’s leading independent Site Management Organization.

“We are delighted to have dealspan as partners. The successful funding round and dealspan’s backing will support investment across Europe with the FutureMeds Dedicated Research Site Network growing to 12 sites by the end of 2021. We have already found their advice invaluable, and they quickly assimilated our business opportunity and we are confident they will be key partners into helping us achieve our strategic ambitions.”

- Dr Radoslaw Janiak, CEO of FutureMeds.

Dealspan’s team with over 25 years of experience will continue to provide strategic advice with Ged Gould joining the Board to help turbocharge the growth plans of FutureMeds.

As per FutureMeds’ roadmap, Dedicated Research Sites will be opened in Bulgaria, the United Kingdom and Ukraine in the coming months.

Ged Gould, Founding Director of Dealspan commented “It is a pleasure to partner with the team at FutureMeds again. The market opportunity is strong for FutureMeds and we look forward to advising the team on their journey.”

About FutureMeds

FutureMeds is a fast-growing independent Dedicated Research Site Network supporting pharmaceutical companies, Sponsors and CROs and contributing to research to find effective treatments and medications for all patients who need them.

FutureMeds’ Dedicated Research Site teams strive to accelerate study timelines, streamline processes, lower costs and improve data quality to help accelerate patient access to new treatments.

Through acquisitions and a strategic focus on patient experience, FutureMeds has developed qualified patient pools across Europe that enables faster patient enrollment and strong retention and help generate more accurate results.

Follow us on LinkedIn

Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.


Los comentarios se han desactivado.
bottom of page